Article
A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer.
International journal of molecular sciences - 31 Aug 2017
Lampignano Rita, Yang Liwen, Neumann Martin H D, Franken André, Fehm Tanja, Niederacher Dieter, Neubauer Hans
Abstract excerpt
Circulating tumor cells (CTCs), potential precursors of most epithelial solid tumors, are mainly enriched by epithelial cell adhesion molecule (EpCAM)-dependent technologies. Hence, these approaches may overlook mesenchymal CTCs, considered highly malignant. Our aim was to establish a workflow to enrich and isolate patient-matched EpCAMhigh and EpCAMlow/negative CTCs within the same blood samples, and to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.